Skip to content
CancerIndex

Publication

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.

Authors not recorded

J Exp Med2012PMID 23045605PMC3478932stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 2

Curated evidence

Evidence citing this paper (1)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
23045605
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
GLIS2 Fusion1
(diagnostic)Acute Myeloid Leukemia With CBFA2T3::GLIS2 FusionUNRESOLVEDDiagnosticBSupports Positive4accepted
EID11885

In this 2012 study the authors performed high-throughput sequencing of RNA (RNA-seq) of leukemic cells obtained after engraftment in immunodeficient mice from 5 patients with Acute megakaryoblastic le… (full text at CIViC)

PMID 23045605 · Thiollier et al., 2012 · Open in CIViC

civic